REQUEST A DEMO
Total
USD $0.00
Search more companies

Myco Medic Sdn. Bhd. (Malaysia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Myco Medic Sdn. Bhd. Profile Updated: August 31, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English Download a sample report

Myco Medic Sdn. Bhd. is a company in Malaysia, with a head office in Petaling Jaya. It operates in the Drugs and Druggists' Sundries Merchant Wholesalers industry. The company was established on October 17, 2011. There was a net sales revenue drop of 45.18% reported in Myco Medic Sdn. Bhd.’s latest financial highlights for 2022. Its’ total assets recorded a growth of 31.28%.

Headquarters
B510, Block B Kelana Square,, Jalan Ss7/26, Kelana Jaya
Petaling Jaya; Selangor; Postal Code: 47301

Contact Details: Purchase the Myco Medic Sdn. Bhd. report to view the information.

Website: http://www.mycomedic.com.my

Basic Information
Outstanding Shares:
Purchase the Myco Medic Sdn. Bhd. report to view the information.
Registered Capital:
Purchase the Myco Medic Sdn. Bhd. report to view the information.
Financial Auditors:
Purchase the Myco Medic Sdn. Bhd. report to view the information.
Incorporation Date:
October 17, 2011
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Secretary
Ownership Details
Purchase this report to view the information.
80%
Purchase this report to view the information.
20%
Company Performance
Financial values in the chart are available after Myco Medic Sdn. Bhd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency MYR. Absolute financial data is included in the purchased report.
Net sales revenue
-45.18%
Total operating revenue
-45.18%
Operating profit (EBIT)
495.5%
EBITDA
218.33%
Net Profit (Loss) for the Period
N/A
Total assets
31.28%
Total equity
86.08%
Operating Profit Margin (ROS)
4.76%
Net Profit Margin
N/A
Return on Equity (ROE)
N/A
Debt to Equity Ratio
-6.81%
Quick Ratio
-12.16%
Cash Ratio
-3.6%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?